Miruvor
Sign up
Long COVID Outcome unclear

Long COVID, six months of tirzepatide: slow 11 kg loss, few side effects, costly

Condition
Long COVID
At worst
Not stated
Ill for
Not stated
Last post
Apr 2026
In their words
Read from 2 of their posts and comments; links to the 2 this page draws on

Request to remove this story

Summary

Maple 76376, a UK-based person, reported taking tirzepatide, with weight loss slowed by lack of exercise. After six months they had lost 11 kg, described the loss as slow, and said side effects had been few and far between. They also reported benefits in reducing inflammation and re-regulating the metabolic system, but paid for the drug themselves and called it costly.

Ask Miruvor AI

Asking aboutMaple 76376’s story

What they tried

Their words about each treatment
  • Tirzepatide · HelpedBut it’s having all kinds of additional benefits in terms of reducing inflammation and re-regulating the metabolic system. In context ↗

Ask Miruvor AI

Asking aboutMaple 76376’s story

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime